FM6 844
710
Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or OlderM. Froehner, R. Koch, M. Hübler, S. Zastrow, M.P. Wirth
Stricter selection may diminish the prognostic significance of several common
diseases in men undergoing radical prostatectomy aged 70 yr or older, whereas
other parameters (peripheral vascular disease, cerebrovascular disease, American
Society of Anesthesiologists class 3, current smoking, and level of education)
sustained their meaningfulness. Knowing these parameters may be helpful in
tailoring individual treatment strategies in elderly patients with early prostate
cancer.
714
Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial CarcinomaT. Seisen, T. Jindal, P. Karabon, A. Sood, J. Bellmunt, M. Rouprêt, J.J. Leow, M.W. Vetterlein,
M. Sun, S. Alanee, T.K. Choueiri, Q.-D. Trinh, M. Menon, F. Abdollah
Chemotherapy plus radical nephroureterectomy may be associated with an overall
survival benefit compared to chemotherapy alone for fit patients with metastatic
upper tract urothelial carcinoma. These preliminary results warrant further
consideration in randomized control trials addressing this question.
719
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell CarcinomaA. Bex, L. Albiges, B. Ljungberg, K. Bensalah, S. Dabestani, R.H. Giles, F. Hofmann, M. Hora,
M.A. Kuczyk, T.B. Lam, L. Marconi, A.S. Merseburger, M. Staehler, A. Volpe, T. Powles
Two studies (ASSURE and S-TRAC) recently reported findings on whether adjuvant
VEGF-targeted therapy can improve outcomes for patients with renal cell cancer.
The poor benefit-to-harm ratio and the still absent evidence of an overall survival
benefit led the European Association of Urology Renal Cell Cancer Guidelines Panel
to provide a (weak) recommendation against the use of adjuvant sunitinib in this
setting. Kidney cancer patients—through the International Kidney Cancer Coalition—
participated in a questionnaire on the implications for S-TRAC, and approximately
one-third of patients favoured not taking sunitinib.
723
Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working GroupJ.W. Collins, A. Hosseini, C. Adding, T. Nyberg, A. Koupparis, E. Rowe, M. Perry, R. Issa,
M.C. Schumacher, C. Wijburg, A.E. Canda, M.D. Balbay, K. Decaestecker, C. Schwentner, A. Stenzl,
S. Edeling, S. Pokupic´, F. D’Hondt, A. Mottrie, P.N. Wiklund
This multi-institutional series analyses early recurrence patterns among patients
undergoing robot-assisted radical cystectomy for bladder cancer. No unusual
recurrence patterns were identified. Early recurrence rates and locations appear
similar to those for open series. Pathologic staging and lymph node status were
associated with recurrences.
727
Upholding Rigorous Standards: Comparable Patterns and Rates of Recurrence Between Open and Robot-assisted Radical CystectomyN. Rajarubendra, M. Aron
729
Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate CancerP.J. Gray, C.C. Lin, M.R. Cooperberg, A. Jemal, J.A. Efstathiou
In an analysis of almost 600 000 men diagnosed with localized prostate cancer
between 2004 and 2012, we found that rates of radical prostatectomy had
increased across risk groups. Sociodemographic variables were strongly associated
with management choices.
738
Patterns of Care for Prostate Cancer Patients: Predictors of Care, But For Whom?S.B. Williams, B.F. Chapin
e u r o p e a n u r o l o g y , vo l . 7 1 , n o . 5 , Ma y 2 0 1 7
Prostate Cancer
Platinum Priorities
Brief Correspondence,
Original Articles, Review Article
and Guidelines together
with the Full Length Editorials
Brief Correspondence